Drug development and commercialization
Search documents
Cingulate(CING) - Prospectus
2024-09-27 10:24
As filed with the Securities and Exchange Commission on September 26, 2024 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CINGULATE INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 2834 86-3825535 (Primary Standard Industrial Classification Code Number) If this Form is filed to register additional securities for an ...
Cingulate(CING) - Prospectus
2024-01-12 22:03
As filed with the Securities and Exchange Commission on January 12, 2024 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CINGULATE INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 2834 86-3825535 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 1901 W. 47th Place Kansas ...
Jyong Biotech Ltd(MENS) - Prospectus(update)
2023-10-18 15:19
As filed with the Securities and Exchange Commission on October 18, 2023 Registration Statement No. 333-274042 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 1 TO FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ____________________________ Jyong Biotech Ltd. (Exact name of Registrant as specified in its charter) ____________________________ Not Applicable (Translation of Registrant's name into English) Cogency Global Inc. 122 East 42 nd Street, 18 th F ...
Soleno Therapeutics(SLNO) - Prospectus
2023-07-21 20:10
Table of Contents As filed with the Securities and Exchange Commission on July 21, 2023 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT Under Delaware 3841 77-0523891 (Primary Standard Industrial Classification Code Number) The Securities Act of 1933 (I.R.S. Employer Identification Number) 203 Redwood Shores Pkwy, Suite 500 Redwood City, CA 94065 (650) 213-8444 (Address, Including Zip Code, and Telephone Number, Including Area Cod ...
Soligenix(SNGX) - Prospectus(update)
2023-04-20 01:57
Table of Contents As filed with the Securities and Exchange Commission on April 19, 2023. Registration No. 333-271049 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SOLIGENIX, INC. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number) Delaware 2834 41-1505029 (I.R.S. Employer Ident ...
Tenax Therapeutics(TENX) - Prospectus(update)
2023-01-31 22:16
As filed with the U.S. Securities and Exchange Commission on January 31, 2023 Registration No. 333-269363 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A Amendment No. 1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Tenax Therapeutics, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 2834 26-2593535 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identific ...